KIT and neoplasm: The V558Δ; V653A mutant mislocalization of Golgi, and lead to the enhanced activation of STAT3 and STAT5, although no differences were seen in MAPK or PI3K pathway activation, therefore, contributing to the increased tumor oncogenesis, compared to control mice with a single V558Δ Kit mutation.